ALXN1840

ALXN1840 · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for ALXN1840, covering 2023-07-03 to 2024-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease [Phase 3]